Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $26.6B |
| FY2017, ended Dec 31, 2017 | $31.4B |
| FY2018, ended Dec 31, 2018 | $39.8B |
| FY2019, ended Dec 31, 2019 | $39.1B |
| FY2020, ended Dec 31, 2020 | $26.9B |
| FY2021, ended Dec 31, 2021 | $36.2B |
| FY2022, ended Dec 31, 2022 | $51.9B |
| FY2023, ended Dec 31, 2023 | $53.6B |
| FY2024, ended Dec 31, 2024 | $43.6B |
| FY2025, ended Dec 31, 2025 | $47.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $71.8B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $63.3B |
| FY2017, ended Dec 31, 2017 | $74.7B |
| FY2018, ended Dec 31, 2018 | $86.1B |
| FY2019, ended Dec 31, 2019 | $111B |
| FY2020, ended Dec 31, 2020 | $69.8B |
| FY2021, ended Dec 31, 2021 | $120B |
| FY2022, ended Dec 31, 2022 | $177B |
| FY2023, ended Dec 31, 2023 | $148B |
| FY2024, ended Dec 31, 2024 | $139B |
| FY2025, ended Dec 31, 2025 | $133B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $154B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.17B | $1.13B |
| FY2017, ended Dec 31, 2017 | $3.43B | $3.88B |
| FY2018, ended Dec 31, 2018 | $2.78B | $2.98B |
| FY2019, ended Dec 31, 2019 | $2.64B | $4.63B |
| FY2020, ended Dec 31, 2020 | −$9.83B | −$368M |
| FY2021, ended Dec 31, 2021 | $9.74B | $2.90B |
| FY2022, ended Dec 31, 2022 | $14.5B | $13.9B |
| FY2023, ended Dec 31, 2023 | $9.68B | $12.2B |
| FY2024, ended Dec 31, 2024 | $3.44B | $6.13B |
| FY2025, ended Dec 31, 2025 | $4.05B | $4.77B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.55B | $12.9B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $887M |
| FY2017, ended Dec 31, 2017 | $3.01B |
| FY2018, ended Dec 31, 2018 | $1.69B |
| FY2019, ended Dec 31, 2019 | $1.39B |
| FY2020, ended Dec 31, 2020 | $415M |
| FY2021, ended Dec 31, 2021 | $5.29B |
| FY2022, ended Dec 31, 2022 | $8.63B |
| FY2023, ended Dec 31, 2023 | $5.44B |
| FY2024, ended Dec 31, 2024 | $3.21B |
| FY2025, ended Dec 31, 2025 | $3.67B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.77B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.6B |
| FY2017, ended Dec 31, 2017 | $12.9B |
| FY2018, ended Dec 31, 2018 | $27.5B |
| FY2019, ended Dec 31, 2019 | $28.7B |
| FY2020, ended Dec 31, 2020 | $31.6B |
| FY2021, ended Dec 31, 2021 | $25.5B |
| FY2022, ended Dec 31, 2022 | $26.7B |
| FY2023, ended Dec 31, 2023 | $27.3B |
| FY2024, ended Dec 31, 2024 | $27.5B |
| FY2025, ended Dec 31, 2025 | $32.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $32.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 46.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 528M |
| FY2017, ended Dec 31, 2017 | 476M |
| FY2018, ended Dec 31, 2018 | 674M |
| FY2019, ended Dec 31, 2019 | 650M |
| FY2020, ended Dec 31, 2020 | 651M |
| FY2021, ended Dec 31, 2021 | 565M |
| FY2022, ended Dec 31, 2022 | 446M |
| FY2023, ended Dec 31, 2023 | 361M |
| FY2024, ended Dec 31, 2024 | 313M |
| FY2025, ended Dec 31, 2025 | 295M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 281M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $197M | $45.0M | $11.0M | — |
| FY2017, ended Dec 31, 2017 | $2.37B | $51.0M | $46.0M | — |
| FY2018, ended Dec 31, 2018 | $3.29B | $127M | $24.0M | $19.8B |
| FY2019, ended Dec 31, 2019 | $1.95B | $153M | $10.0M | — |
| FY2020, ended Dec 31, 2020 | $0 | $100M | $11.0M | — |
| FY2021, ended Dec 31, 2021 | $4.65B | $88.0M | $106M | — |
| FY2022, ended Dec 31, 2022 | $11.9B | $153M | $243M | — |
| FY2023, ended Dec 31, 2023 | $11.6B | $211M | $62.0M | — |
| FY2024, ended Dec 31, 2024 | $9.19B | $137M | $25.0M | — |
| FY2025, ended Dec 31, 2025 | $3.49B | $160M | $24.0M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.93B | — | $3.00M | — |
Valuation
At current price- Market Cap
- $122B
- P/E
- 14.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.8×
- Price / Book
- 6.4×
- EV / EBITDA
- 8.5×
Growth
Trailing 12 months- Revenue (TTM)
- $154B
- Revenue Growth YoY
- 15.0%
- Revenue CAGR 3Y
- −9.2%
- Revenue CAGR 5Y
- 13.7%
- EPS Growth YoY
- 319%
- Net Income Growth YoY
- 301%
Profitability
Trailing 12 months- Gross Margin
- 12.5%
- Operating Margin
- 9.2%
- Net Margin
- 5.6%
- FCF Margin
- 8.4%
- Return on Equity
- 47.9%
Earnings
Trailing 12 months- Net Income
- $8.55B
- EPS (diluted)
- $28.84
- EBITDA
- $17.4B
- Operating Income
- $14.1B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $7.77B
- Total Debt
- $32.8B
- Net Debt
- $25.0B
- Total Assets
- $94.3B
- Total Liabilities
- $68.6B
- Shareholders' Equity
- $19.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $17.1B
- Capital Expenditure
- $4.23B
- Free Cash Flow
- $12.9B
Dividends and risk
Last 12 months- Dividend Yield
- 0.9%
- Dividend / Share
- $4.00
- Beta (5Y)
- 0.54
Every ratio is calculated from the company’s reported figures.